1-苄基-1H-咪唑-5-甲醛 | 85102-99-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1-苄基-1H-咪唑-5-甲醛
• 英文名称: 1-benzyl-1H-imidazole-5-carboxaldehyde
• 英文别名: 1-benzyl-1H-imidazole-5-carbaldehyde；1-benzyl-5-imidazolecarboxaldehyde；1-benzylimidazole-5-carboxaldehyde；1-benzyl-5-formylimidazole；1-benzylimidazole-5-carbaldehyde；3-benzyl-3H-imidazole-4-carbaldehyde；3-benzylimidazole-4-carbaldehyde
• CAS: 85102-99-4
• 化学式: C₁₁H₁₀N₂O
• 分子量: 186.213
• InChiKey: QONDAZCJAPQGRX-UHFFFAOYSA-N

物化性质

• 熔点：
  46-49°C
• 沸点：
  201-203 °C(Press: 23 Torr)
• 密度：
  1.12±0.1 g/cm3(Predicted)
• 溶解度：
  扩张型心肌病

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  34.9
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 海关编码：
  2933290090
• 安全说明：
  S26,S36/37/39
• WGK Germany：
  3
• 储存条件：
  Keep Cold

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Benzyl-1H-imidazole-5-carboxaldehyde
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H319: Causes serious eye irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Benzyl-1H-imidazole-5-carboxaldehyde
CAS number: 85102-99-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C11H10N2O
Molecular weight: 186.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-苄基-1H-咪唑-5-甲醛 在 lithium aluminium tetrahydride 、 氯化亚砜 作用下， 以 四氢呋喃 为溶剂， 反应 0.58h， 生成 1-Benzyl-5-(chloromethyl)-1H-imidazolium chloride
  参考文献：
  名称：

  稳定同位素特异性标记的L-组氨酸的合成

  摘要：

  （2'- 13 C）-，（1'- 15 N）-和（3'- 15 N）-L-组氨酸是根据允许13 C或15对所有碳和氮位置或位置的任何组合进行N标记。通过将甲苯磺酰基甲基异氰化物与3-苯基丙烯醛缩合并随后环加苄胺来构建1，5-二取代的咪唑环。将咪唑中间体转化为1-苄基-5-（氯甲基）-咪唑鎓氯化物，其通过与环D-戊基甘氨酸的双内酯醚的对映选择性偶联而与甘氨酸部分偶联。偶联产物的脱保护得到高光学纯度的L-组氨酸。同位素标记的合成子的合成是从简单的，可商购的，高度富集的化合物开始的。通过质谱和1 H-，13 C-和15表征标记的L-组氨酸N-NMR光谱。

  DOI：

  10.1002/recl.19941130603
• 作为产物：
  描述：

  1-苄基-5-羟甲基-1H-咪唑 在 manganese(IV) oxide 作用下， 以 1,4-二氧六环 为溶剂， 反应 6.0h， 以78%的产率得到1-苄基-1H-咪唑-5-甲醛
  参考文献：
  名称：

  Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase

  摘要：

  报道了一系列含有咪唑基的肽模拟物PFTase抑制剂及其与PFTase和FPP结合的共晶结构。这些结构揭示了肽模拟物采取类似于延伸的CVIM四肽的构象，其中的咪唑基团与催化锌离子配位。含有单咪唑和双咪唑的衍生物13和16，在体外分别表现出对PFTase极高的酶抑制活性，IC50值分别为0.86和1.7 nM。这些肽模拟物对PFTase的选择性优于PGGTase-I，无论是在体外还是在完整的细胞中。此外，肽模拟物13和16在裸鼠异种移植模型中能抑制肿瘤生长，以每天25 mg kg−1的剂量给药时没有明显的毒性。

  DOI：

  10.1039/b508184j
• 作为试剂：
  描述：

  1-苄基咪唑-4-甲醛 、 在 1-苄基-1H-咪唑-5-甲醛 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 lithium chloride 作用下， 以 乙腈 为溶剂， 以54 %的产率得到
  参考文献：
  名称：

  Hybridization into a Bitopic Ligand Increased Muscarinic Receptor Activation for Isopilocarpine but Not for Pilocarpine Derivatives

  摘要：

  DOI：

  10.1021/acs.jnatprod.2c01079

文献信息

• [EN] METHYLAMINE DERIVATIVES AS LYSYSL OXIDASE INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE LA MÉTHYLAMINE COMME INHIBITEURS DE LA LYSYL OXIDASE POUR LE TRAITEMENT DU CANCER
  申请人：THE INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL

  公开号：WO2017141049A1

  公开（公告）日：2017-08-24

  Provided are compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, wherein W, X, Y, Z, x, R1, R2, R3, x and n are defined in the specification. The compounds are inhibitors of lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) family members (LOXL1, LOXL2, LOXL3, LOXL4) and are useful in therapy, particularly in the treatment of cancer. Also disclosed are LOX inhibitors for use in the treatment of a cancer associated with EGFR and biomarkers that predict responsiveness to a LOX inhibitor.

  提供的是Formula (I)的化合物，或其药用可接受的盐，其中W、X、Y、Z、x、R1、R2、R3、x和n在规范中有定义。这些化合物是赖氨酸氧化酶（LOX）和赖氨酸氧化酶样（LOXL）家族成员（LOXL1、LOXL2、LOXL3、LOXL4）的抑制剂，并且在治疗中很有用，特别是在癌症治疗中。还披露了用于治疗与EGFR相关的癌症的LOX抑制剂，以及预测对LOX抑制剂响应性的生物标志物。
• QUINAZOLINONES AS PARP14 INHIBITORS
  申请人：Ribon Therapeutics Inc.

  公开号：US20190194174A1

  公开（公告）日：2019-06-27

  The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.

  本发明涉及喹唑啉酮和相关化合物，它们是PARP14的抑制剂，例如在癌症和炎症性疾病的治疗中是有用的。
• Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
  申请人：——

  公开号：US20040204417A1

  公开（公告）日：2004-10-14

  The invention concerns compounds of general formula (1), wherein, in particular; W represents H, SO 2 R 5 . CO(CH 2 ) n R 5 , (CH 2 ) n R 6 , CS(CH 2 ) n R 5 ; X represents S or NH; Y represents (CH 2 ) p , CO, (CH 2 ) p CO, CH═CH—CO; Z represents a hetcrocycle, imidazole, benzimidazole, isoxazole, tetrazole, oxadiazole, thiadazole, pyridine, quinazoline, quinoxaline, quinoline, thiophene; R 1 represents COOR 6 , CONR 6 R 7 , CO—NH—CH(R 6 )—COOR 7 , CH 2 NR 6 R 7 , CH 2 OR 6 , (CH 2 ) p R 6 , CH═CHR 6 ; R 2 represents in particular hydrogen, C 1 -C 10 alkyl, a substituted or unsubstituted phenyl; R 5 and R 6 represents hydrogen, C 1 —C 6 alkyl; R 5 represents a substituted or unsubstituted phenyl or naphthyl; R 6 and R 7 , identical or different, represent hydrogen, C 1 —C 15 alkyl, a hetcrocycle. an aryl; n represents 0 to 10; p represents 1 to 6. 1

  该发明涉及一般式（1）的化合物，其中，特别是；W代表H，SO2R5.CO(CH2)nR5，(CH2)nR6，CS(CH2)nR5；X代表S或NH；Y代表(CH2)p，CO，(CH2)pCO，CH═CH—CO；Z代表杂环，咪唑，苯并咪唑，异噁唑，四唑，噁二唑，硫唑，吡啶，喹唑啉，喹喔啉，喹啉，噻吩；R1代表COOR6，CONR6R7，CO—NH—CH(R6)—COOR7，CH2NR6R7，CH2OR6，(CH2)pR6，CH═CHR6；R2特指氢，C1-C10烷基，取代或未取代苯基；R5和R6代表氢，C1—C6烷基；R5代表取代或未取代苯基或萘基；R6和R7，相同或不同，代表氢，C1—C15烷基，杂环，芳基；n表示0到10；p表示1到6。
• Expedient access to saturated nitrogen heterocycles by photoredox cyclization of imino-tethered dihydropyridines
  作者：Noah B. Bissonnette、J. Michael Ellis、Lawrence G. Hamann、Fedor Romanov-Michailidis

  DOI：10.1039/c9sc03429c

  日期：——

  relevant molecules bear nitrogen and sp3-hybridized carbon functionalities. Overwhelmingly, these atoms are found as part of (hetero)cyclic structures. Despite their importance, synthetic approaches to saturated nitrogen heterocycles are limited to several established stoichiometric alkylation techniques, as well as a few methods involving C-H bond activation. The synthetic community remains interested

  大部分与医学相关的分子具有氮和sp3杂化的碳官能团。绝大多数情况下，发现这些原子是（杂环）环状结构的一部分。尽管它们的重要性，但饱和氮杂环的合成方法仅限于几种已建立的化学计量烷基化技术，以及一些涉及CH键活化的方法。合成社区仍然对访问这些主题的更一般，温和和可持续的方式感兴趣。在这里，我们描述了一种由铱光催化剂和磷酸锂碱组成的双催化剂体系，该体系能够通过质子偶联电子转移（PCET）选择性地均化4-烷基-1,4-二氢吡啶的NH键。 ，并通过束缚的亚胺介导生成的碳中心自由基的有效环化。
• Regiochemistry of N-substitution of some 4(5)-substituted imidazoles under solvent-free conditions
  作者：Larisa Oresmaa、Helena Taberman、Matti Haukka、Pirjo Vainiotalo、Paula Aulaskari

  DOI：10.1002/jhet.5570440632

  日期：2007.11

  Imidazole-4(5)-carboxaldehyde and 4(5)-cyanoimidazole were N-benzylated and N-methylated using benzyl chloride and methyl iodide on zinc oxide (ZnO), alumina, and KF/alumina under basic conditions without solvent. Triethylamine (Et3N) or potassium carbonate was added as base in the reactions on ZnO and alumina. Imidazole-4(5)-carboxaldehyde was also benzylated on silica and carbon nanotubes. The effect

  在碱性条件下，在无溶剂的情况下，使用苄基氯和甲基碘在氧化锌（ZnO），氧化铝和KF /氧化铝上对N-苄基化和N-甲基化咪唑4（5）-甲醛和4（5）-氰基咪唑。在ZnO和氧化铝上的反应中，加入三乙胺（Et 3 N）或碳酸钾作为碱。咪唑-4（5）-甲醛在二氧化硅和碳纳米管上也被苄基化。研究了碱和固体对1,4-和1,5-取代的化合物的产物分布的影响。在某些情况下，咪唑-4（5）-甲醛和4（5）-氰基咪唑的产物比率不同。在KF /氧化铝上的反应中，两种化合物都偏爱1,4-产物。Et 3的组合N和ZnO有利于1,5-产物，但是腈的作用并不那么明显。当在催化量的氯化锌以Et 3 N为碱的条件下进行醛的N-苄基化和甲基化时，产物分布与在ZnO上的反应相同。在ZnCl 2存在下，腈在ZnO上给出不同的产物比率。另外，当咪唑在KF /氧化铝上被苄基化时，产生了N-苄基咪唑和1，3-二苄基咪唑的混合物。当使用两当量的苄基氯时，仅提供后者的产物。